Android app Apple app link

Cancer drug startup Tubulis raises $361 million for ADCs

By Yahoo! Finance   |   1 month ago
Cancer drug startup Tubulis raises $361 million for ADCs

Antibody-drug conjugates (ADCs) are revolutionizing cancer treatment, with AstraZeneca and Daiichi Sankyo's Enhertu leading the way.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.